B
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
Price:
20.4
INR
1.9%
Market Closed
Market Cap:
₹1.1B
Relative Value
The Relative Value of one BALAXI stock under the Base Case scenario is hidden INR. Compared to the current market price of 20.4 INR, Balaxi Pharmaceuticals Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BALAXI Relative Value
HIDDEN
Multiples Across Competitors
BALAXI Competitors Multiples
Balaxi Pharmaceuticals Ltd Competitors
Balaxi Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
B
|
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
|
1.1B INR | 0.4 | 12 | 6.2 | 6.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
117.4B USD | 0.3 | 27.1 | 19.1 | 21.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
70.9B USD | 0.2 | 43.6 | 15.3 | 19.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.9B USD | 0.2 | 43.7 | 15.3 | 19.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.5B USD | 0.2 | 32.1 | 15.4 | 20 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.7B AUD | 5.8 | 65.4 | 49.4 | 49.4 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.9B USD | 0.8 | 25.1 | 11.9 | 16.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.2B CNY | 0.2 | 11.4 | 15.3 | 15.3 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.2B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
68.5B HKD | 0.1 | 8.9 | 1.7 | 2.1 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
